From concept to FDA trials: how GCMI & T3 Labs helped Strataca fight AKI
Read how GCMI and T3 worked together to help John Erbey at Strataca develop a new way to manage Acute Kidney Injury (AKI)
As of November 30, 2023 T3 Labs is Part of Veranex. Click Here to learn more.
GCMI Design & Development has moved to gcmiatl.org